• About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact
About About

About

Abcuro.com

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Tse, Loretta

October 4, 2026

Loretta Tse, PhD, is Investment Director at Aberdeen Investments and is responsible for investment in the Aberdeen Healthcare funds. Loretta joined the company in November 2022 from Tekla Capital Management LLC where she was a Vice President investing in venture. Previously, Loretta worked for the Fred Hutchinson Cancer Research Center and Oxford Biosciences Partners. Loretta graduated with a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine.

Loretta Tse, PhD

Observer
Investment Director, Aberdeen Investments

x

Loretta Tse, PhD

Observer
Investment Director, Aberdeen Investments

Loretta Tse, PhD, is Investment Director at Aberdeen Investments and is responsible for investment in the Aberdeen Healthcare funds. Loretta joined the company in November 2022 from Tekla Capital Management LLC where she was a Vice President investing in venture. Previously, Loretta worked for the Fred Hutchinson Cancer Research Center and Oxford Biosciences Partners. Loretta graduated with a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine.

Privacy Terms of Use

© 2026 Abcuro